These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 21159830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 3. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L, Marchetti F, Tommasini A, Ventura A.
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B, Xu T, Li Y, Yin X.
    Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD010893. PubMed ID: 30338514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A.
    Arthritis Rheumatol; 2017 Apr 19; 69(4):854-862. PubMed ID: 27860460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H.
    Clin Exp Rheumatol; 2006 Apr 19; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 13. Anakinra for colchicine refractory familial Mediterranean fever: a cohort of 44 patients.
    Marko L, Shemer A, Lidar M, Grossman C, Druyan A, Livneh A, Kivity S.
    Rheumatology (Oxford); 2021 Jun 18; 60(6):2878-2883. PubMed ID: 34144604
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
    Erten S, Erten SF, Altunoglu A.
    Rheumatol Int; 2012 Apr 18; 32(4):1095-7. PubMed ID: 21431291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.
    Sakallioglu O, Duzova A, Ozen S.
    Clin Exp Rheumatol; 2006 Apr 18; 24(4):435-7. PubMed ID: 16956436
    [Abstract] [Full Text] [Related]

  • 19. Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial.
    Ben-Zvi I, Livneh A.
    Isr Med Assoc J; 2014 May 18; 16(5):271-3. PubMed ID: 24979828
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.